Provided by Tiger Trade Technology Pte. Ltd.

Ceribell

23.94
-0.2600-1.07%
Pre-market: 23.46-0.4800-2.01%08:39 EDT
Volume:408.94K
Turnover:9.80M
Market Cap:918.77M
PE:-13.60
High:24.33
Open:23.95
Low:23.65
Close:24.20
52wk High:25.33
52wk Low:10.85
Shares:38.38M
Float Shares:26.49M
Volume Ratio:0.91
T/O Rate:1.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7600
EPS(LYR):-1.4617
ROE:-43.93%
ROA:-23.38%
PB:7.16
PE(LYR):-16.38

Loading ...

Company Profile

Company Name:
Ceribell
Exchange:
NASDAQ
Establishment Date:
2014
Employees:
327
Office Location:
360 North Pastoria Avenue,Sunnyvale,California,United States
Zip Code:
94085
Fax:
- -
Introduction:
CeriBell, Inc. was incorporated in Delaware on August 29, 2014. It is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company developed the Ceribell System, a novel point-of-care EEG platform that combines proprietary, highly portable, rapidly deployable hardware with sophisticated AI-driven algorithms to enable rapid diagnosis and continuous monitoring of neurological patients in acute care settings. By making EEG more accessible and enabling continuous monitoring through AI, the Ceribell System allows clinicians to diagnose and manage patients at risk of seizures more quickly and accurately, improving patient outcomes and economic efficiency for hospitals and payers.

Directors

Name
Position
Xingjuan Chao
Chief Executive Officer,Director and President
Rebecca Robertson
Director and Chair of the Board
Erica Rogers
Director
Josef Parvizi
Director
Joseph M. Taylor
Director
Juliet Tammenoms Bakker
Director
William W. Burke
Director

Shareholders

Name
Position
Xingjuan Chao
Chief Executive Officer,Director and President
Scott Blumberg
Chief Financial Officer
Joseph S. Manni
Chief Revenue Officer
Raymond Woo
Chief Technology Officer